These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6190231)

  • 21. Occurrence of antiperinuclear, antikeratin, and anti-RA 33 antibodies in juvenile chronic arthritis.
    Gabay C; Prieur AM; Meyer O
    Ann Rheum Dis; 1993 Nov; 52(11):785-9. PubMed ID: 7504436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-RA 33 antinuclear autoantibody in rheumatoid arthritis and mixed connective tissue disease: comparison with antikeratin and antiperinuclear antibodies.
    Meyer O; Tauxe F; Fabregas D; Gabay C; Goycochea M; Haim T; Elias A; Kahn MF
    Clin Exp Rheumatol; 1993; 11(5):473-8. PubMed ID: 7506130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies.
    Sebbag M; Simon M; Vincent C; Masson-Bessière C; Girbal E; Durieux JJ; Serre G
    J Clin Invest; 1995 Jun; 95(6):2672-9. PubMed ID: 7539459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical relevance of antikeratin antibodies in rheumatoid arthritis and symmetric polyarthritis associated with hepatitis C infection.
    Cojocaru M; Cojocaru IM; Iacob SA
    Rom J Intern Med; 2004; 42(4):709-14. PubMed ID: 16366142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of antikeratin antibodies in rheumatoid arthritis.
    Hajiroussou VJ; Skingle J; Gillett AP; Webley M
    J Rheumatol; 1985 Feb; 12(1):57-9. PubMed ID: 2580092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial antibodies and subclinical liver disease.
    Walker JG; Doniach D; Doniach I
    Q J Med; 1970 Jan; 39(153):31-48. PubMed ID: 4193516
    [No Abstract]   [Full Text] [Related]  

  • 27. Prospect for an additional laboratory criterion for rheumatoid arthritis.
    von Essen R; Kurki P; Isomäki H; Okubo S; Kautiainen H; Aho K
    Scand J Rheumatol; 1993; 22(6):267-72. PubMed ID: 7505480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serological profile in so-called seronegative rheumatoid arthritis].
    Moineau MP; Youinou P; Le Goff P; Ferec C; Miossec P; Brousse A; Le Saout J
    Rev Rhum Mal Osteoartic; 1984 Feb; 51(2):91-5. PubMed ID: 6200919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis.
    Granito A; Muratori P; Muratori L; Pappas G; Cassani F; Worthington J; Ferri S; Quarneti C; Cipriano V; de Molo C; Lenzi M; Chapman RW; Bianchi FB
    Aliment Pharmacol Ther; 2007 Sep; 26(6):831-8. PubMed ID: 17767467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiperinuclear antibodies. An argument in favor of the autoimmune nature of a liver disease?].
    Youinou P; Miossec P; Jouquan J; Mottier D; Ferrec C; Le Goff P
    Gastroenterol Clin Biol; 1983 Feb; 7(2):218-9. PubMed ID: 6601600
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparing HEp-2 cell line with rat liver in routine screening test for antinuclear and antinucleolar autoantibodies in autoimmune diseases.
    Prost AC; Abuaf N; Rouquette-Gally AM; Homberg JC; Combrisson A
    Ann Biol Clin (Paris); 1987; 45(6):610-7. PubMed ID: 3326434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiperinuclear factor as a prognostic marker in rheumatoid arthritis.
    Muñoz-Fernández S; Alvarez-Doforno R; González-Tarrio JM; Balsa A; Richi P; Fontán G; Gijón-Baños J; Martin-Mola E
    J Rheumatol; 1999 Dec; 26(12):2572-7. PubMed ID: 10606364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
    Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
    Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An eight year prospective study of outcome prediction by antiperinuclear factor and antikeratin antibodies at onset of rheumatoid arthritis.
    Genevay S; Hayem G; Verpillat P; Meyer O
    Ann Rheum Dis; 2002 Aug; 61(8):734-6. PubMed ID: 12117683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Specific antibodies for the early diagnosis of rheumatoid arthritis].
    Li H; Li X; Gan X
    Zhonghua Yi Xue Za Zhi; 2000 Jan; 80(1):20-4. PubMed ID: 11798731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis.
    Remmel T; Piirsoo A; Koiveer A; Remmel H; Uibo R; Salupere V
    Hepatogastroenterology; 1996; 43(11):1135-40. PubMed ID: 8908541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical relevance of antikeratin antibodies in rheumatoid arthritis.
    Miossec P; Youinou P; Le Goff P; Moineau MP
    Clin Rheumatol; 1982 Sep; 1(3):185-9. PubMed ID: 6205812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.
    Schellekens GA; de Jong BA; van den Hoogen FH; van de Putte LB; van Venrooij WJ
    J Clin Invest; 1998 Jan; 101(1):273-81. PubMed ID: 9421490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiperinuclear factor and keratin antibodies in rheumatoid arthritis.
    Johnson GD; Carvalho A; Holborow EJ; Goddard DH; Russell G
    Ann Rheum Dis; 1981 Jun; 40(3):263-6. PubMed ID: 6166255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Problems of immuno-gerontology: research on anti-nuclear antibodies in old age].
    Ghigliotti G; Azzena D; Azzolini A; Battaglia A
    Acta Gerontol (Milano); 1967; 17(4):202-11. PubMed ID: 4179189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.